Structure–Activity Relationship Studies of Mitogen Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 and BCR-ABL1 Inhibitors Targeting Chronic Myeloid Leukemic Cells

Author:

Cherian Joseph1,Nacro Kassoum1,Poh Zhi Ying1,Guo Samantha1,Jeyaraj Duraiswamy A.1,Wong Yun Xuan1,Ho Melvyn1,Yang Hai Yan1,Joy Joma Kanikadu1,Kwek Zekui Perlyn1,Liu Boping1,Wee John Liang Kuan1,Ong Esther HQ1,Choong Meng Ling1,Poulsen Anders1,Lee May Ann1,Pendharkar Vishal1,Ding Li Jun1,Manoharan Vithya1,Chew Yun Shan1,Sangthongpitag Kanda1,Lim Sharon2,Ong S. Tiong2,Hill Jeffrey1,Keller Thomas H.1

Affiliation:

1. Experimental Therapeutics Centre, 13 Biopolis Way, Nanos, Singapore 138669

2. Duke-National University of Singapore (NUS) Graduate Medical School, 8 College Road, Singapore, Singapore 169857

Funder

Agency for Science, Technology and Research

National Medical Research Council

Joint Council Office, Agency for Science, Technology and Research

Biomedical Sciences Institutes

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3